{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:03:26Z","timestamp":1758672206913,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1086,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Education, Cultures, Sports, Science and Technology (MEXT) of Japan"},{"name":"Department of Medical Sciences, Ministry of Public Health of Thailand"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.virol.2010.06.003","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T04:36:31Z","timestamp":1277267791000},"page":"129-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors"],"prefix":"10.1016","volume":"405","author":[{"given":"Masanori","family":"Kameoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panasda","family":"Isarangkura-na-ayuthaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Kameoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sompong","family":"Sapsutthipas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bongkot","family":"Soonthornsata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pathom","family":"Sawanpanyalert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wattana","family":"Auwanit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2010.06.003_bib1","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1099\/vir.0.80137-0","article-title":"Selected amino acid substitutions in the C-terminal region of human immunodeficiency virus type 1 capsid protein affect virus assembly and release","volume":"85","author":"Abdurahman","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/jvi.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"Adachi","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib3","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1089\/08892220050116970","article-title":"Polymorphism of HIV type 1 gag p7\/p1 and p1\/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors","volume":"16","author":"Bally","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2010.06.003_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/viro.1996.0266","article-title":"Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag\/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1","volume":"219","author":"Barrie","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.003_bib5","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1128\/JVI.72.9.7532-7541.1998","article-title":"In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor","volume":"72","author":"Carrillo","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/jvi.68.1.111-122.1994","article-title":"Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells","volume":"68","author":"Chazal","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virol.2005.12.009","article-title":"A domain directly C-terminal to the major homology region of human immunodeficiency type 1 capsid protein plays a crucial role in directing both virus assembly and incorporation of Gag\u2013Pol","volume":"348","author":"Chien","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.003_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/JVI.75.2.589-594.2001","article-title":"Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and\/or saquinavir","volume":"75","author":"Cote","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib9","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1128\/JVI.77.17.9422-9430.2003","article-title":"Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?","volume":"77","author":"de Oliveira","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib10","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1128\/jvi.70.6.3763-3769.1996","article-title":"Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors","volume":"70","author":"Doyon","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.1999.0178","article-title":"Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication","volume":"268","author":"Fitzon","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.003_bib12","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1128\/JVI.72.7.6004-6013.1998","article-title":"Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex","volume":"72","author":"Fouchier","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/372359a0","article-title":"Specific incorporation of cyclophilin A into HIV-1 virions","volume":"372","author":"Franke","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.virol.2010.06.003_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.278.5339.849","article-title":"Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein","volume":"278","author":"Gamble","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.virol.2010.06.003_bib15","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection","volume":"296","author":"Gaschen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.virol.2010.06.003_bib16","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1074\/jbc.M108005200","article-title":"Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors","volume":"277","author":"Gatanaga","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2010.06.003_bib17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1089\/aid.2005.21.1016","article-title":"Covariability of selected amino acid positions for HIV type 1 subtypes C and B","volume":"21","author":"Gilbert","year":"2005","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2010.06.003_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.273.5272.231","article-title":"Structure of the amino-terminal core domain of the HIV-1 capsid protein","volume":"273","author":"Gitti","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.virol.2010.06.003_bib19","doi-asserted-by":"crossref","first-page":"W13","DOI":"10.1097\/01.aids.0000247564.73009.bc","article-title":"Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004","volume":"20","author":"Hemelaar","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2010.06.003_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.virol.2008.05.029","article-title":"Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)\/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response","volume":"378","author":"Ho","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.003_bib21","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1128\/jvi.71.6.4472-4478.1997","article-title":"Incorporation of Pr160(gag\u2013pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag\u2013Pol polyprotein","volume":"71","author":"Huang","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0042-6822(89)90431-5","article-title":"Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens","volume":"170","author":"Ikuta","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.003_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/QAI.0b013e3181b4b18c","article-title":"Impact of amino acid variations in Gag and protease of HIV type 1 CRF01_AE strains on drug susceptibility of virus to protease inhibitors","volume":"52","author":"Jinnopat","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virol.2010.06.003_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/bbrc.1999.0964","article-title":"HIV-1 Tat protein is poly(ADP-ribosyl)ated in vitro","volume":"261","author":"Kameoka","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2010.06.003_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/08892220151126526","article-title":"Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs","volume":"17","author":"Kaufmann","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2010.06.003_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virol.2007.11.033","article-title":"Inhibitory function of adapter-related protein complex 2 alpha 1 subunit in the process of nuclear translocation of human immunodeficiency virus type 1 genome","volume":"373","author":"Kitagawa","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.003_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0092-8674(93)90637-6","article-title":"Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B","volume":"73","author":"Luban","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.virol.2010.06.003_bib28","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1128\/jvi.68.8.4927-4936.1994","article-title":"Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis","volume":"68","author":"Mammano","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib29","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.1128\/JVI.72.9.7632-7637.1998","article-title":"Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients","volume":"72","author":"Mammano","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib30","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/aid.2004.20.1119","article-title":"Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains","volume":"20","author":"Marlowe","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"Suppl 1","key":"10.1016\/j.virol.2010.06.003_bib31","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/jmv.20599","article-title":"Global epidemiology of HIV","volume":"78","author":"McCutchan","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/AAC.48.2.444-452.2004","article-title":"Gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1","volume":"48","author":"Myint","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2010.06.003_bib33","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1128\/JVI.02356-08","article-title":"Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1","volume":"83","author":"Parry","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib34","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1128\/JVI.78.21.12030-12040.2004","article-title":"Amino acid insertions near Gag cleavage sites restore the otherwise compromised replication of human immunodeficiency virus type 1 variants resistant to protease inhibitors","volume":"78","author":"Tamiya","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/372363a0","article-title":"Functional association of cyclophilin A with HIV-1 virions","volume":"372","author":"Thali","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.virol.2010.06.003_bib36","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2010.06.003_bib37","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1128\/JVI.73.12.10329-10338.1999","article-title":"Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus","volume":"73","author":"Varthakavi","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.003_bib38","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1128\/jvi.71.9.6662-6670.1997","article-title":"Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites","volume":"71","author":"Zhang","year":"1997","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682210003831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682210003831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:08:25Z","timestamp":1758586105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682210003831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0042682210003831"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2010.06.003","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2010.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}